YANCOPOULOS GEORGE (President and CSO) exercised options at REGENERON PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2026ACC: 0001226690-26-000002
DirectorOfficer· President and CSO
Since Nov 2015
-28.57K
Net shares
Net seller
$22.06M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
28.57K acquired · 57.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28.57K
Price / share
—
Trade value
—
% of position
9.2%
12/31/2025
310.46K→339.03K
Common Stock
Direct
Shares
−28.57K
Price / share
$772.09
Trade value
$22.06M
% of position
8.4%
12/31/2025
339.03K→310.46K
Total
Net shares
+0.00
Net value
-$22.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | M · Option Exercise | +28.57K | — | — | 9.2% | 310.46K | 339.03K |
| Common Stock Direct | 12/31/2025 | F · Tax Withholding | −28.57K | $772.09 | $22.06M | 8.4% | 339.03K | 310.46K |
| Total | +0.00 | -$22.06M | ||||||
Derivative Transactions1
2020 Performance Stock Units
Direct
Converts to
Common Stock
28.57K shares
Shares
−28.57K
Strike price
Held after
595.08K
Exercisable
—
12/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| 2020 Performance Stock Units Direct | Common Stock28.57K shares | 12/31/2025 | M · Option Exercise | −28.57K | — | 595.08K |
Non-Derivative Holdings (Post-Transaction)7
Common Stock
IndirectShares owned101.99K
Common Stock
IndirectShares owned5.96K
Common Stock
IndirectShares owned180K
Common Stock
IndirectShares owned200K
Common Stock
IndirectShares owned56.05K
Common Stock
IndirectShares owned200K
Common Stock
IndirectShares owned71.49K
Total
815.49K indirect815.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 101.99K | Indirect |
| Common Stock | 5.96K | Indirect |
| Common Stock | 180K | Indirect |
| Common Stock | 200K | Indirect |
| Common Stock | 56.05K | Indirect |
| Common Stock | 200K | Indirect |
| Common Stock | 71.49K | Indirect |
| Total | 815.49K | 815.49K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported